{
    "Trade/Device Name(s)": [
        "GLUCOCARD 01 Blood Glucose Monitoring System",
        "ReliOn Confirm Blood Glucose Monitoring System"
    ],
    "Submitter Information": "ARKRAY Factory, Inc.",
    "510(k) Number": "K142336",
    "Predicate Device Reference 510(k) Number(s)": [
        "K124021"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA"
    ],
    "Summary Letter Date": "August 20, 2014",
    "Summary Letter Received Date": "August 21, 2014",
    "Submission Date": "August 20, 2014",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "GLUCOCARD 01 Blood Glucose Meter",
        "ReliOn Confirm Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for GLUCOCARD 01 and ReliOn Confirm Blood Glucose Monitoring Systems with modifications to exterior meter materials.",
    "Indications for Use Summary": "Quantitative measurement of glucose in fresh capillary whole blood from fingertips or palm for at-home diabetes monitoring; not for diagnosis, screening, neonates, or multipatient use.",
    "fda_folder": "Clinical Chemistry"
}